Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption is the process where drugs filtered into the renal tubule transport back into the bloodstream, primarily through passive diffusion. This reabsorption increases drug half-life by reducing renal elimination. Most exogenous drugs, particularly nonionized weakly acidic or basic drugs, undergo passive reabsorption in the distal convoluted tubule where drug concentration increases, enabling diffusion back into peritubular capillaries.

Urine pH alters drug ionization through ion trapping, a mechanism that prevents reabsorption. Alkaline urine ionizes weak acidic drugs, keeping them in the tubular lumen for excretion. Acidic urine ionizes weak basic drugs, similarly enhancing excretion. Since drug pKa is constant, manipulating urine pH directly controls ionization state and reabsorption rates, making it a clinical tool for overdose management.

Ionized drugs have decreased permeability through tubular cell membranes due to their charged structure, preventing passive diffusion back into the bloodstream. Nonionized drugs are lipophilic and highly permeable, allowing them to cross cell membranes easily. This difference in membrane permeability is the basis for ion trapping, where ionization prevents reabsorption and promotes urinary excretion of unwanted substances.

Active reabsorption requires energy and is common for endogenous substances like glucose and electrolytes; oxopurinol is a rare drug example. Passive reabsorption, typical for most drugs, relies on concentration gradients and lipophilicity without energy expenditure. Passive reabsorption is driven by back diffusion of nonionized, permeable drugs along concentration gradients established during glomerular filtration.

Diuretic therapy and large alcohol consumption increase renal blood flow to the peritubular capillaries, reducing the time available for drug reabsorption. This enhanced blood flow decreases drug concentration gradients in the tubular lumen, limiting passive diffusion back into the bloodstream and increasing overall drug excretion and clearance.

The urine-plasma ratio reflects the distribution of a drug between urine and plasma, indicating the extent of reabsorption. For weakly acidic or basic drugs, this ratio depends on urine pH and the drug's pKa. A low ratio suggests significant reabsorption, while a high ratio indicates minimal reabsorption and greater urinary excretion of the drug.

Bicarbonate alkalinizes the urine, converting weakly acidic drugs like phenobarbital into their ionized forms. Ionized phenobarbital cannot cross tubular cell membranes, remaining trapped in the urine for excretion. This ion trapping mechanism prevents reabsorption and dramatically increases renal clearance, reducing drug toxicity and promoting faster elimination.